Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-07

Clinical Trial Update: PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing PUVA alone vs PUVA with interferon alfa-2a in mycosis fungoides was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon alpha-2a (interferon alfa-2a)
  • PUVA therapy (psoralen + UVA) (psoralen + ultraviolet A)

Snippet

Sponsor: Madrilenian Group of Cutaneous Lymphomas | Conditions: Cutaneous T-Cell Lymphoma (Mycosis Fungoides) | Phase 4 | Status: TERMINATED